Düsseldorf, Germany – November is traditionally a decisive month for global medical innovation. It is when the world turns its eyes to the MEDICA Trade Fair, held in Germany.

For Cardios, participating in this event is not just an exposure opportunity, but a reaffirmation of our commitment to pioneering. Representing the strength of the Brazilian health industry, we arrived in Düsseldorf with a clear mission: to showcase how our Holter technology continues to elevate diagnostic standards with precision and applied intelligence.

In this article, we share the highlights of our participation in MEDICA 2025 and the impact of these connections for cardiology in Brazil and worldwide.

The Grandeur of MEDICA: The Center of Global Innovation

For those in the health sector, MEDICA needs no introduction, but its numbers impress with each edition. Considered the largest B2B medical fair in the world, the event transforms the Düsseldorf exhibition center into a global hub for business and science.

The 2025 edition brought together:

• Over 80,000 visitors from various nationalities;

• About 5,000 exhibitors showcasing the future of medicine;

• Hundreds of conferences on trends and new technologies.

Being present in this setting, specifically in Hall 16 (Stand D41-8), places Cardios side by side with the largest players in the international market.

The Cardios Holter: Pioneering Without Borders

Our greatest competitive advantage has always been our complete mastery of the technology we develop. At MEDICA 2025, the highlight of our booth was undoubtedly the Holter.

We presented to the global audience not just a device but the result of decades of enhancement. The international reception reinforces that Brazilian technology possesses the robustness, accuracy, and signal quality necessary to compete in the most demanding markets in Europe and worldwide.

Strategic Connections: Halma Group and Hospitalar

An event of this magnitude goes far beyond product displays; it is about strategic relationships. During the fair days, our booth was the stage for meetings that strengthen our corporate structure and our vision for the future.

The Visit from the Halma Group

We had the honor of welcoming Steve Brown, CEO of the medical sector at Halma, the international holding company that acquired Cardios in 2017. The visit provided valuable exchanges on innovation and strategic alignments, reinforcing the positive impact of Cardios inside and outside Brazil under the management of a global group.

Brazilian Representation

We also received Fábio Stringhini, Commercial Manager of Hospitalar and representative of the Healthcare Innovation Show (HIS). In a conversation with our director, Erica Chringer, the strength of the national industry was discussed. The joint presence of Cardios and Hospitalar in Germany symbolizes the maturity of the Brazilian healthcare sector.

These connections, also made possible with the fundamental support of ABIMO (Brazilian Association of Medical Device Industry), are essential for expanding our market vision and closely following the trends that will transform cardiology in the coming years.

The Future is Now

Participation in MEDICA 2025 renews our energy and confirms that we are on the right path. We return to Brazil with our bags full of new partnerships, technological insights, and the certainty that Cardios remains at the forefront, offering Brazilian doctors the latest advancements in the world, with the confidence of being a pioneer.